KBIO COMPANY Inc. (KOSDAQ:038530)
South Korea flag South Korea · Delayed Price · Currency is KRW
312.00
+26.00 (9.09%)
Last updated: Aug 7, 2025
9.09%
Market Cap34.88B
Revenue (ttm)81.01B
Net Income (ttm)-7.01B
Shares Out115.50M
EPS (ttm)-60.92
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,771,170
Average Volume1,437,440
Open286.00
Previous Close286.00
Day's Range281.00 - 314.00
52-Week Range209.00 - 453.00
Beta0.94
RSI62.18
Earnings DateAug 14, 2025

About Verve Therapeutics

KBIO COMPANY Inc. engages in the bio distribution business. The company supplies experimental equipment and various reagents to general hospitals, universities, research institutes, etc.; and engages in distribution, bidding, equipment rental, and other business. It serves through online and offline stores. The company was formerly known as Gold Pacific Co., Ltd. and changed its name to KBIO COMPANY Inc. in June 2023. KBIO COMPANY Inc. was founded in 1997 and is headquartered in Seongnam, South Korea. [Read more]

Industry Electronic Components And Accessories
Founded 1997
Employees 33
Stock Exchange KOSDAQ
Ticker Symbol 038530
Full Company Profile

Financial Performance

In 2024, KBIO COMPANY's revenue was 76.51 billion, an increase of 180.02% compared to the previous year's 27.32 billion. Losses were -6.79 billion, -46.42% less than in 2023.

Financial Statements

News

There is no news available yet.